scispace - formally typeset
D

Dong Hyun Sinn

Researcher at Samsung Medical Center

Publications -  286
Citations -  5416

Dong Hyun Sinn is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 34, co-authored 224 publications receiving 3531 citations. Previous affiliations of Dong Hyun Sinn include Inje University & Sungkyunkwan University.

Papers
More filters
Journal ArticleDOI

Preoperative gadoxetic acid–enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma

TL;DR: A combination of two or more of the following; arterial per itumoral enhancement, non-smooth tumor margin, and peritumoral hypointensity on hepatobiliary phase, can be used as a preoperative imaging biomarker for predicting MVI, with specificity >90%, and is associated with early recurrence after surgery of single HCC.
Journal ArticleDOI

Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation.

TL;DR: The MVI prediction model predicted the risk of MVI in patients with a small HCC with high accuracy and patients with MVI who had undergone RFA were more vulnerable to recurrence than those who had underwent SR.
Journal ArticleDOI

Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment

TL;DR: LLV observed during entecavir monotherapy was associated with a higher risk of HCC, especially for those with cirrhosis, indicating that LLV during potent antiviral therapy is consequential.
Journal ArticleDOI

Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study

TL;DR: NAFLD was significantly associated with the development of CAC independent of cardiovascular and metabolic risk factors and may play a pathophysiological role in atherosclerosis development and may be useful to identify subjects with a higher risk of subclinical disease progression.